In NAFLD, excessive NLRP3 activation not only triggers hepatic inflammation but may also inhibit autophagy, aggravating lipid metabolism disorders (Del Campo et al., 2018; Yang et al., 2016). This evidence concerns the gene NLRP3 and metabolic dysfunction-associated steatotic liver disease.